BioNTech (Germany)

Last week, Pfizer and BioNTech filed for emergency authorization of their coronavirus vaccine with the Food and Drug Administration.

Pharmaceutical manufacturer Pfizer began shipping doses of its COVID-19 vaccine Friday via chartered cargo flights between Brussels, Belgium, and Chicago to have stockpiles in position for distribution as soon as it is approved for inoculations by regulators, The Wall...

Don't let the COVID crisis put a damper on your Thanksgiving Day.  Several years ago the founder of the Association of Mature American Citiz

SCI COMMUN### Infectious diseases The 11th Ebola outbreak in the Democratic Republic of the Congo (DRC) is officially over, giving the country respite from the disease for the first time in more than 2 years. On 18 November, the World Health Organization (WHO) announced that no new cases had been identified for 42 days, twice the incubation period for the deadly virus. The outbreak, in the western Équateur…

Crude oil prices are trading at the highest levels since March on positive news related to Covid-19 vaccine and diminishing concerns over weak demand next year. Fundamental analysis: Improving risk sentiment  Crude oil prices gained on the announcements from three major drugmakers including Pfizer-BioNTech, Moderna and Oxford that the coronavirus vaccine rollouts could begin in December.  "Despite a number of…

Scientists urge the Oxford University team to begin a new large-scale trial to prove the "serendipitous observation."

The comments come ahead of a Dec. 10 meeting where FDA regulators will review Pfizer and BioNTech's request for an emergency use authorization for their COVID-19 vaccine.

LONDON (AP) — The British government said Friday it has formally asked the country's medicines regulator to assess whether a coronavirus vaccine developed by AstraZeneca and Oxford University should be

Long before Moderna and Pfizer's COVID-19 shots, scientists had been considering the use of genetically encoded vaccines in the fight against infectious diseases, cancer, and more.

The race to bring vaccines to market is nearing the finish line. Determining which product can best contain the pandemic, however, will take more time.

The vaccine trials against the Coronavirus are giving great news to the world. The efficacy of Pfizer and BioNtech is promising and the first batch of vaccines may be coming in December to the US. But what bothers on the other side is the largest growing number of cases and deaths recorded in the US

The U.S. plans to send 6.4 million doses of Pfizer's COVID-19 vaccine across the U.S. within 24 hours of the vaccine getting emergency use authorization from the Food and Drug Administration, officials said Tuesday. The goal is to distribute 40 million doses of vaccines from Pfizer and Moderna by the end of the year, enough to vaccinate 20 million people. States were informed of their allocations on Friday, and…

If regulators approve any of the vaccines in coming weeks, the distribution could begin almost immediately

Crude oil prices have continued to rise due to the optimism of a COVID-19 vaccine. Furthermore, investors are waiting for data on the U.S oil inventories.

Expected distribution in mid-December will be based on population.

Hospital-based nurses, doctors, custodians are among the state's "first tier" of vaccine recipients once the U.S. Food and Drug Administration approves one or more for the public.

Initial distribution estimated at 6.4 million doses; coordination with Biden transition now underway

Value investing is a tried and true style of investing especially perfect for uncertain times- like now. Our deep learning algorithms have identified several Top U.S. Value ETFs for November.

What the latest Covid-19 vaccine announcements from AstraZeneca-Oxford, Pfizer-BioNTech, and Moderna can and can't tell us.